FDA Panel Votes to Approve Pfizer’s Vaccine for Children
Oct. 26, 2021 — The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA. Seventeen of the 18 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Tuesday voted to recommend the 10-microgram shot for … Read more